Barriers to Gene Delivery Using Synthetic Vectors

被引:66
作者
Read, Martin L. [1 ]
Logan, Ann [1 ]
Seymour, Leonard W. [2 ]
机构
[1] Univ Birmingham, Dept Med, Mol Neurosci Grp, Wolfson Res Labs, Birmingham B15 2TH, W Midlands, England
[2] Univ Oxford, Dept Clin Pharmacol, Oxford OX2 6HE, England
来源
NON-VIRAL VECTORS FOR GENE THERAPY, 2ND EDITION: PART 1 | 2005年 / 53卷
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1016/S0065-2660(05)53002-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Progress has been made in the development of different types of nucleic acids such as DNA and siRNA with the potential to form the basis of new treatments for genetic and acquired disorders. The lack of suitable vectors for the delivery of nucleic acids, however, represents a major hurdle to their continued development and therapeutic application. Synthetic vectors based on polycations are promising vectors for gene delivery as they are relatively safe and can be modified by the incorporation of ligands for targeting to specific cell types. However, the levels of gene expression mediated by synthetic vectors are low compared to viral vectors. The aim of this chapter is to give an overview of the main barriers that have been identified as limiting gene transfer using polycation-based synthetic vectors. The chapter is divided into two sections to focus on both extracellular and intracellular barriers. We describe novel strategies that are being used to develop increasingly sophisticated vectors in an attempt to overcome these barriers. For instance, we describe approaches to prolong the plasma circulation of polyplexes by the incorporation onto their surface of hydrophilic polymers such as polyethylene glycol (PEG) and poly[N-(2-hydroxypropyl)methacrylamide] (pHPMA). In addition, strategies to improve transfer of nucleic acids from the outside of the cell to the nucleus are described to overcome barriers such as escape from endocytic vesicles and translocation across the nuclear membrane. Furthermore, we highlight new types of vectors based on reducible polycations that are triggered by the intracellular environment to facilitate efficient cytoplasmic release of nucleic acids. (C) 2005, Elsevier Inc.
引用
收藏
页码:19 / 46
页数:28
相关论文
共 82 条
[1]   Metabolic stability of glutaraldehyde cross-linked peptide DNA condensates [J].
Adami, RC ;
Rice, KG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (08) :739-746
[2]   Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity [J].
Aoki, K ;
Furuhata, S ;
Hatanaka, K ;
Maeda, M ;
Remy, JS ;
Behr, JP ;
Terada, M ;
Yoshida, T .
GENE THERAPY, 2001, 8 (07) :508-514
[3]   Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells [J].
Bettinger, T ;
Carlisle, RC ;
Read, ML ;
Ogris, M ;
Seymour, LW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (18) :3882-3891
[4]  
Bettinger T, 2001, CURR OPIN MOL THER, V3, P116
[5]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[6]   A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA [J].
Brandén, LJ ;
Mohamed, AJ ;
Smith, CIE .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :784-787
[7]   Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery [J].
Bremner, KH ;
Seymour, LW ;
Logan, A ;
Read, ML .
BIOCONJUGATE CHEMISTRY, 2004, 15 (01) :152-161
[8]  
Bremner KH, 2001, CURR OPIN MOL THER, V3, P170
[9]   Cell cycle dependence of gene transfer by lipoplex polyplex and recombinant adenovirus [J].
Brunner, S ;
Sauer, T ;
Carotta, S ;
Cotten, M ;
Saltik, M ;
Wagner, E .
GENE THERAPY, 2000, 7 (05) :401-407
[10]   Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin α [J].
Ciolina, C ;
Byk, G ;
Blanche, F ;
Thuillier, V ;
Scherman, D ;
Wils, P .
BIOCONJUGATE CHEMISTRY, 1999, 10 (01) :49-55